CoreX Peptides
Retatrutide
Retatrutide
5.0 / 5.0
(1) 1 total reviews
Couldn't load pickup availability
Retatrutide is a next-generation synthetic peptide designed for advanced preclinical research. As a triple incretin receptor agonist, it simultaneously targets GLP-1R, GIPR, and glucagon receptors, making it one of the most mechanistically complex compounds available for metabolic signalling research in 2026.
Research applications include:
- Multi-receptor agonism studies (GLP-1R / GIPR / Glucagon receptor)
- Metabolic and energy homeostasis pathway modelling
- Comparative receptor engagement vs single and dual agonist compounds
- Gut-brain axis and appetite regulation research
Product specifications:
- Form: Lyophilised powder
- Purity: ≥99%
- Storage: −20°C, protected from light and moisture
- Available strengths: 20mg · 40mg - 60mg
⚠ For research purposes only. This product is not intended for human or veterinary use, consumption, or self-administration. Must be handled by qualified professionals in a suitable laboratory environment. Not evaluated by the MHRA or any regulatory authority for therapeutic use.
Share
I've been using retatrutide for a while now, and it's been a positive experience overall. The first couple of weeks came with a noticeable decrease in appetite. What I noticed most was that I wasn't constantly thinking about food anymore, and it became much easier to make healthier choices without feeling like I was forcing myself.